Search results (11)
« Back to News & EventsNew vaccines that aim to prevent cancer: Starting the conversation
28 March 2025
Join us for a joint event from the Centre for Personalised Medicine (CPM) & Oxford Centre for Cancer Early Detection and Prevention (OxCODE) on Monday 2nd June 2025.
CRUK funding for therapeutic HPV vaccine to prevent HPV-associated cancers
25 March 2025
Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.
Dr David Church awarded Senior Cancer Research Fellowship from Cancer Research UK
21 March 2025
David’s research will focus on immune dysregulation in colorectal and endometrial pre-cancers and cancers.
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
27 January 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Oxford Centre for Cancer Early Detection and Prevention celebrates 5 years at its 2024 Symposium
3 January 2025
On 10-11th December, we celebrated 5 years since the launch of OxCODE with a showcase of Oxford’s most successful cancer early detection and prevention programmes.
Funding to create world's first ovarian cancer prevention vaccine
4 October 2024
Researchers from Oxford have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.
Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome
10 September 2024
Cancer Research UK funds University of Oxford scientists to develop ‘LynchVax’, the UK’s first vaccine aiming to prevent cancer in people with Lynch syndrome who have a much higher risk of developing several types of cancer.
Oxford hosts industry event on cancer precision prevention trials
17 July 2024
Professor Sarah Blagden led a panel discussion focused on the opportunities of cancer precision prevention.
OxCODE researchers at the inaugural Cancer Prevention Research conference 2024
4 July 2024
Over 20 Oxford researchers engaged with over 350 attendees from all over the world at a truly interdisciplinary cancer prevention conference.
£1.7 million for vaccine to prevent lung cancer
22 March 2024
Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.
Oxford Cancer Precision Prevention Symposium – a recap
1 December 2023
To celebrate the launch of the UK’s first CRUK clinical trials unit dedicated to cancer precision prevention in Oxford, we held a research symposium that highlighted the spectra of Cancer Precision Prevention clinical programmes across the UK.